AstraZeneca Cuts Two Alexion Products as Fourth Quarter Earnings Surpass Projections

AstraZeneca Cuts Two Alexion Products as Fourth Quarter Earnings Surpass Projections

AstraZeneca Cuts Two Alexion Products as Fourth Quarter Earnings Surpass Projections